| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049033886 |
| P356 | DOI | 10.1038/BJC.2012.35 |
| P932 | PMC publication ID | 3305960 |
| P698 | PubMed publication ID | 22333595 |
| P5875 | ResearchGate publication ID | 221831748 |
| P2093 | author name string | T Takahashi | |
| K Nakajima | |||
| M Mori | |||
| Y Fujiwara | |||
| H Ishii | |||
| Y Kurokawa | |||
| M Yamasaki | |||
| H Miyata | |||
| S Takiguchi | |||
| Y Doki | |||
| F Tanaka | |||
| H Miyagaki | |||
| P2860 | cites work | Cell cycle control of wnt receptor activation | Q24294429 |
| Functional characterization of human PFTK1 as a cyclin-dependent kinase | Q24306566 | ||
| Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1 | Q24338160 | ||
| p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus | Q27851533 | ||
| Minimum information about a microarray experiment (MIAME)-toward standards for microarray data | Q27860569 | ||
| Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma | Q28207491 | ||
| Microarray data normalization and transformation | Q29617789 | ||
| Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray. | Q33211547 | ||
| Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc | Q33914646 | ||
| Cyclin-dependent kinases: a family portrait. | Q34036740 | ||
| Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1). | Q35034758 | ||
| Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis | Q35606026 | ||
| Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells | Q37205578 | ||
| Cyclin-dependent kinase inhibitors as potential targeted anticancer agents | Q37407079 | ||
| Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. | Q37449181 | ||
| Cyclin-dependent kinase inhibitors as anticancer drugs. | Q37704502 | ||
| Regulation of Lrp6 phosphorylation | Q37709217 | ||
| The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC. | Q39711315 | ||
| PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma | Q39719499 | ||
| Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. | Q39737918 | ||
| Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma | Q40018569 | ||
| Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells | Q40121986 | ||
| A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression | Q40359228 | ||
| CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. | Q40455557 | ||
| Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies | Q42914870 | ||
| Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy v | Q43629491 | ||
| Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer | Q43737749 | ||
| Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. | Q43961349 | ||
| Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial | Q44017893 | ||
| Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. | Q44022873 | ||
| FBXO31 determines poor prognosis in esophageal squamous cell carcinoma | Q44259706 | ||
| Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. | Q44691624 | ||
| Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus | Q44808761 | ||
| A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). | Q46304729 | ||
| Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. | Q53297361 | ||
| Overexpression of CDK2 is a prognostic indicator of oral cancer progression. | Q55100601 | ||
| Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma | Q57546312 | ||
| The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma | Q71737358 | ||
| Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression | Q74029730 | ||
| Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers | Q74445228 | ||
| Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer | Q77738544 | ||
| Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer | Q77996259 | ||
| The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus | Q80224934 | ||
| Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis | Q82672510 | ||
| Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma | Q82896294 | ||
| Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers | Q83025451 | ||
| [2010 TNM system: on the 7th edition of TNM classification of malignant tumors] | Q84726041 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 947-954 | |
| P577 | publication date | 2012-02-14 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma | |
| P478 | volume | 106 |
| Q53064658 | Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma. |
| Q92593856 | CDK14 involvement in proliferation migration and invasion of esophageal cancer |
| Q38797641 | Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway |
| Q38120534 | Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development |
| Q48200216 | Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer. |
| Q38755837 | Knockdown of PFTK1 Expression by RNAi Inhibits the Proliferation and Invasion of Human Non-Small Lung Adenocarcinoma Cells |
| Q38847276 | Knockdown of PFTK1 Inhibits the Migration of Glioma Cells |
| Q102217033 | MiR-205 inhibits sporadic vestibular schwannoma cells proliferation by targeting cyclin-dependent kinase 14 |
| Q35815916 | PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion |
| Q38943983 | Serine/threonine-protein kinase PFTK1 modulates oligodendrocyte differentiation via PI3K/AKT pathway |
| Q38922051 | Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel |
| Q34097654 | Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy |
| Q36241608 | Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16. |
| Q26827580 | Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors |
| Q27025081 | The function and molecular mechnism of cyclin Y protein |
| Q38868671 | Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer |
| Q47121115 | miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14. |
Search more.